Use promo code “TCH15” to get 15% off on checkout.

AI-powered Cancer Vaccine

Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers

Jan 23, 2020

Tech News

AI-powered Cancer Vaccine, NEC, Transgene

Mark Ko

TOKYO, Jan 7, 2020 – (JCN Newswire) – Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation, a leader in IT and network technologies, have announced that the first patients have been enrolled in the first-in-human trials evaluating TG4050, a therapeutic vaccine based on the myvac…